Neuroprotective mechanisms of PPARδ: Modulation of oxidative stress and inflammatory processes

PPAR Research

Volumn , Issue , 2011, Pages

  Schnegg, Caroline I ^a   Robbins, Mike E ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 [4 [2 [3 CYCLOHEXYL 1 (4 CYCLOHEXYLBUTYL)UREIDO]ETHYL]PHENYLTHIO] 2 METHYLPROPIONIC ACID; 4 [4 [3 (4 ACETYL 3 HYDROXY 2 PROPYLPHENOXY)PROPOXY]PHENOXY]ACETIC ACID; [2 METHYL 4 [4 METHYL 2 (4 TRIFLUOROMETHYLPHENYL) 5 THIAZOLYLMETHYLTHIO]PHENOXY]ACETIC ACID; [4 [2 (3 FLUORO 4 TRIFLUOROMETHYLPHENYL) 4 METHYL 5 THIAZOLYLMETHYLTHIO] 2 METHYLPHENOXY]ACETIC ACID; CYTOKINE; FENOFIBRATE; L 160043; MESSENGER RNA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR DELTA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR DELTA AGONIST; PIOGLITAZONE; UNCLASSIFIED DRUG;

ALLERGIC ENCEPHALOMYELITIS; ALZHEIMER DISEASE; ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; ASTROCYTOSIS; BRAIN CANCER; BRAIN INJURY; BRAIN ISCHEMIA; BRAIN REGION; CANCER RADIOTHERAPY; CENTRAL NERVOUS SYSTEM; CYTOKINE PRODUCTION; DOPAMINERGIC NERVE CELL; GENETIC TRANSCRIPTION; HUMAN; INFLAMMATION; LIPID PEROXIDATION; METASTASIS; MIDDLE CEREBRAL ARTERY OCCLUSION; MULTIPLE SCLEROSIS; NEUROPROTECTION; NONHUMAN; OXIDATIVE STRESS; PARKINSON DISEASE; PATHOGENESIS; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN TARGETING; REVIEW; SPINAL CORD INJURY; STROKE;

EID: 84855281838     PISSN: 16874757     EISSN: 16874765     Source Type: Journal    
DOI: 10.1155/2011/373560     Document Type: Review

References (90)

1. Nuclear Receptors Nomenclature Committee, A unified nomenclature system for the nuclear receptor superfamily Cell 1999 97 2 161 163
2. Lemberger T., Desvergne B., Wahli W., Peroxisome proliferator-activated receptors: a nuclear receptor signaling pathway in lipid physiology Annual Review of Cell and Developmental Biology 1996 12 335 363 (Pubitemid 26422717)
3. Blanquart C., Barbier O., Fruchart J. C., Staels B., Glineur C., Peroxisome proliferator-activated receptors: regulation of transcriptional activities and roles in inflammation Journal of Steroid Biochemistry and Molecular Biology 2003 85 25 267 273 (Pubitemid 37011102)
4. Osumi T., Wen J. K., Hashimoto T., Two cis-acting regulatory sequences in the peroxisome proliferator-responsive enhancer region of rat acyl-CoA oxidase gene Biochemical and Biophysical Research Communications 1991 175 3 866 871
5. Bugge A., Mandrup S., Molecular mechanisms and genome-wide aspects of PPAR subtype specific transactivation PPAR Research 2010 2010 12
6. Moraes L. A., Piqueras L., Bishop-Bailey D., Peroxisome proliferator-activated receptors and inflammation Pharmacology and Therapeutics 2006 110 3 371 385
7. Glass C. K., Saijo K., Winner B., Marchetto M. C., Gage F. H., Mechanisms underlying inflammation in neurodegeneration Cell 2010 140 6 918 934
8. Kapadia R., Yi J. H., Vemuganti R., Mechanisms of anti-inflammatory and neuroprotective actions of PPAR-gamma agonists Frontiers in Bioscience 2008 13 5 1813 1826 (Pubitemid 351599735)
9. Heneka M. T., Landreth G. E., Hll M., Drug insight: effects mediated by peroxisome proliferator-activated receptor-gamma in CNS disorders Nature Clinical Practice Neurology 2007 3 9 496 504 (Pubitemid 47377609)
10. Bordet R., Ouk T., Petrault O., Gelé P., Gautier S., Laprais M., Deplanque D., Duriez P., Staels B., Fruchart J. C., Bastide M., PPAR: a new pharmacological target for neuroprotection in stroke and neurodegenerative diseases Biochemical Society Transactions 2006 34, part 6 1341 1346 (Pubitemid 46769051)
11. Moreno S., Farioli-vecchioli S., Cer M. P., Immunolocalization of peroxisome proliferator-activated receptors and retinoid X receptors in the adult rat CNS Neuroscience 2004 123 1 131 145 (Pubitemid 37518482)
12. Iwashita A., Muramatsu Y., Yamazaki T., Muramoto M., Kita Y., Yamazaki S., Mihara K., Moriguchi A., Matsuoka N., Neuroprotective efficacy of the peroxisome proliferator-activated receptor -selective agonists in vitro and in vivo Journal of Pharmacology and Experimental Therapeutics 2007 320 3 1087 1096 (Pubitemid 46294065)
13. Yin K. J., Deng Z., Hamblin M., Zhang J., Chen Y. E., Vascular PPAR protects against stroke-induced brain injury Arteriosclerosis, Thrombosis, and Vascular Biology 2011 31 3 574 581
14. Polak P. E., Kalinin S., Dello Russo C., Gavrilyuk V., Sharp A., Peters J. M., Richardson J., Willson T. M., Weinberg G., Feinstein D. L., Protective effects of a peroxisome proliferator-activated receptor- / agonist in experimental autoimmune encephalomyelitis Journal of Neuroimmunology 2005 168 1-2 65 75 (Pubitemid 41396404)
15. de la Monte S. M., Tong M., Lester-Coll N., Plater M. Jr., Wands J. R., Therapeutic rescue of neurodegeneration in experimental type 3 diabetes: relevance to Alzheimer's disease Journal of Alzheimer's Disease 2006 10 1 89 109 (Pubitemid 44401370)
16. Chaturvedi R. K., Calingasan N. Y., Yang L., Hennessey T., Johri A., Beal M. F., Impairment of PGC-1alpha expression, neuropathology and hepatic steatosis in a transgenic mouse model of Huntington's disease following chronic energy deprivation Human Molecular Genetics 2010 19 16 3190 3205
17. Pialat J. B., Cho T. H., Beuf O., Joye E., Moucharaffie S., Langlois J. B., Nemoz C., Janier M., Berthezene Y., Nighoghossian N., Desvergne B., Wiart M., MRI monitoring of focal cerebral ischemia in peroxisome proliferator- activated receptor (PPAR)-deficient mice NMR in Biomedicine 2007 20 3 335 342 (Pubitemid 46824533)
18. Arsenijevic D., de Bilbao F., Plamondon J., Paradis E., Vallet P., Richard D., Langhans W., Giannakopoulos P., Increased infarct size and lack of hyperphagic response after focal cerebral ischemia in peroxisome proliferator-activated receptor -deficient mice Journal of Cerebral Blood Flow and Metabolism 2006 26 3 433 445
19. Kanakasabai S., Walline C. C., Chakraborty S., Bright J. J., PPAR deficient mice develop elevated Th1/Th17 responses and prolonged experimental autoimmune encephalomyelitis Brain Research 2011 1376 101 112
20. Dunn S. E., Bhat R., Straus D. S., Sobel R. A., Axtell R., Johnson A., Nguyen K., Mukundan L., Moshkova M., Dugas J. C., Chawla A., Steinman L., Peroxisome proliferator-activated receptor limits the expansion of pathogenic Th cells during central nervous system autoimmunity Journal of Experimental Medicine 2010 207 8 1599 1608
21. Madrigal J. L. M., Kalinin S., Richardson J. C., Feinstein D. L., Neuroprotective actions of noradrenaline: effects on glutathione synthesis and activation of peroxisome proliferator activated receptor delta Journal of Neurochemistry 2007 103 5 2092 2101 (Pubitemid 350126619)
22. Kalinin S., Richardson J. C., Feinstein D. L., A PPARdelta agonist reduces amyloid burden and brain inflammation in a transgenic mouse model of Alzheimer's disease Current Alzheimer Research 2009 6 5 431 437
23. Paterniti I., Esposito E., Mazzon E., Galuppo M., Di Paola R., Bramanti P., Kapoor A., Thiemermann C., Cuzzocrea S., Evidence for the role of peroxisome proliferator-activated receptor- / in the development of spinal cord injury Journal of Pharmacology and Experimental Therapeutics 2010 333 2 465 477
24. Gofflot F., Chartoire N., Vasseur L., Heikkinen S., Dembele D., Le Merrer J., Auwerx J., Systematic gene expression mapping clusters nuclear receptors according to their function in the brain Cell 2007 131 2 405 418 (Pubitemid 47576140)
25. Xing G., Zhang L., Zhang L., Heynen T., Yoshikawa T., Smith M., Weiss S., Detera-Wadleigh S., Rat PPAR contains a CGG triplet repeat and is prominently expressed in the thalamic nuclei Biochemical and Biophysical Research Communications 1995 217 3 1015 1025
26. Woods J. W., Tanen M., Figueroa D. J., Biswas C., Zycband E., Moller D. E., Austin C. P., Berger J. P., Localization of PPAR in murine central nervous system: expression in oligodendrocytes and neurons Brain Research 2003 975 1-2 10 21 (Pubitemid 36588548)
27. Braissant O., Wahli W., Differential expression of peroxisome proliferator-activated receptor-,-, and- during rat embryonic development Endocrinology 1998 139 6 2748 2754 (Pubitemid 28512383)
28. Krémarik-Bouillaud P., Schohn H., Daua M., Regional distribution of PPAR in the cerebellum of the rat Journal of Chemical Neuroanatomy 2000 19 4 225 232
29. Akanuma S. I., Hori S., Ohtsuki S., Fujiyoshi M., Terasaki T., Expression of nuclear receptor mRNA and liver X receptor-mediated regulation of ABC transporter A1 at rat blood-brain barrier Neurochemistry International 2008 52 4-5 669 674
30. Cristiano L., Cimini A., Moreno S., Ragnelli A. M., Paola Cer M., Peroxisome proliferator-activated receptors (PPARs) and related transcription factors in differentiating astrocyte cultures Neuroscience 2005 131 3 577 587 (Pubitemid 40261214)
31. Cristiano L., Bernardo A., Cer M. P., Peroxisome proliferator-activated receptors (PPARs) and peroxisomes in rat cortical and cerebellar astrocytes Journal of Neurocytology 2001 30 8 671 683
32. Moraes L. A., Piqueras L., Bishop-Bailey D., Peroxisome proliferator-activated receptors and inflammation Pharmacology and Therapeutics 2006 110 3 371 385
33. Kostadinova R., Wahli W., Michalik L., PPARs in diseases: control mechanisms of inflammation Current Medicinal Chemistry 2005 12 25 2995 3009 (Pubitemid 41672488)
34. Bishop-Bailey D., Bystrom J., Emerging roles of peroxisome proliferator-activated receptor- / in inflammation Pharmacology and Therapeutics 2009 124 2 141 150
35. Sergeeva M. G., Aleshin S. E., Grabeklis S., Reiser G., PPAR activation has dichotomous control on the expression levels of cytosolic and secretory phospholipase A2 in astrocytes; inhibition in nave, untreated cells and enhancement in LPS-stimulated cells Journal of Neurochemistry 2010 115 2 399 410
36. Pesant M., Sueur S., Dutartre P., Tallandier M., Grimaldi P. A., Rochette L., Connat J. L., Peroxisome proliferator-activated receptor (PPAR ) activation protects H9c2 cardiomyoblasts from oxidative stress-induced apoptosis Cardiovascular Research 2006 69 2 440 449 (Pubitemid 43098800)
37. Girnun G. D., Domann F. E., Moore S. A., Robbins M. E. C., Identification of a functional peroxisome proliferator-activated receptor response element in the rat catalase promoter Molecular Endocrinology 2002 16 12 2793 2801 (Pubitemid 36020658)
38. Planavila A., Rodrguez-Calvo R., Jové M., Michalik L., Wahli W., Laguna J. C., Vzquez-Carrera M., Peroxisome proliferator-activated receptor / activation inhibits hypertrophy in neonatal rat cardiomyocytes Cardiovascular Research 2005 65 4 832 841 (Pubitemid 40249728)
39. Fan Y., Wang Y., Tang Z., Zhang H., Qin X., Zhu Y., Guan Y., Wang X., Staels B., Chien S., Wang N., Suppression of pro-inflammatory adhesion molecules by PPAR- in human vascular endothelial cells Arteriosclerosis, Thrombosis, and Vascular Biology 2008 28 2 315 321 (Pubitemid 351161205)
40. Lee C. H., Chawla A., Urbiztondo N., Liao D., Boisvert W. A., Evans R. M., Curtiss L. K., Transcriptional repression of atherogenic inflammation: modulation by PPAR Science 2003 302 5644 453 457 (Pubitemid 37296272)
41. Takata Y., Liu J., Yin F., Collins A. R., Lyon C. J., Lee C. H., Atkins A. R., Downes M., Barish G. D., Evans R. M., Hsueh W. A., Tangirala R. K., PPAR -mediated antiinflammatory mechanisms inhibit angiotensin II-accelerated atherosclerosis Proceedings of the National Academy of Sciences of the United States of America 2008 105 11 4277 4282 (Pubitemid 351754371)
42. Glatz T., Stck I., Nguyen-Ngoc M., Gohlke P., Herdegen T., Culman J., Zhao Y., Peroxisome-proliferator-activated receptors and peroxisome- proliferator-activated receptors / and the regulation of interleukin 1 receptor antagonist expression by pioglitazone in ischaemic brain Journal of Hypertension 2010 28 7 1488 1497
43. Yin K. J., Deng Z., Hamblin M., Xiang Y., Huang H., Zhang J., Jiang X., Wang Y., Chen Y. E., Peroxisome proliferator-activated receptor regulation of miR-15a in ischemia-induced cerebral vascular endothelial injury Journal of Neuroscience 2010 30 18 6398 6408
44. Basu-Modak S., Braissant O., Escher P., Effect of the peroxisome proliferator-activated receptor activator GW0742 in rat cultured cerebellar granule neurons Journal of Neuroscience Research 2004 77 2 240 249
45. Stinissen P., Raus J., Zhang J., Autoimmune pathogenesis of multiple sclerosis: role of autoreactive T lymphocytes and new immunotherapeutic strategies Critical Reviews in Immunology 1997 17 1 33 75 (Pubitemid 27068807)
46. Benveniste E. N., Role of macrophages/microglia in multiple sclerosis and experimental allergic encephalomyelitis Journal of Molecular Medicine 1997 75 3 165 173 (Pubitemid 27132679)
47. Johns T. G., Kerlero de Rosbo N., Menon K. K., Abo S., Gonzales M. F., Bernard C. C. A., Myelin oligodendrocyte glycoprotein induces a demyelinating encephalomyelitis resembling multiple sclerosis Journal of Immunology 1995 154 10 5536 5541
48. Storch M. K., Stefferl A., Brehm U., Weissert R., Wallstrm E., Kerschensteiner M., Olsson T., Linington C., Lassmann H., Autoimmunity to myelin oligodendrocyte glycoprotein in rats mimics the spectrum of multiple sclerosis pathology Brain Pathology 1998 8 4 681 694 (Pubitemid 28460927)
49. Cimini A., Bernardo A., Cifone M. G., Di Muzio L., Di Loreto S., TNF downregulates PPAR expression in oligodendrocyte progenitor cells: implications for demyelinating diseases GLIA 2003 41 1 3 14 (Pubitemid 36164280)
50. Kanakasabai S., Chearwae W., Walline C. C., Iams W., Adams S. M., Bright J. J., Peroxisome proliferator-activated receptor agonists inhibit T helper type 1 (Th1) and Th17 responses in experimental allergic encephalomyelitis Immunology 2010 130 4 572 588
51. Xiao Y., Xu J., Wang S., Mao C., Jin M., Ning G., Xu J., Zhang Y., Genetic ablation of steroid receptor coactivator-3 promotes PPAR- -mediated alternative activation of microglia in experimental autoimmune encephalomyelitis GLIA 2010 58 8 932 942
52. Kang K., Reilly S. M., Karabacak V., Gangl M. R., Fitzgerald K., Hatano B., Lee C. H., Adipocyte-derived Th2 cytokines and myeloid PPARdelta regulate macrophage polarization and insulin sensitivity Cell Metabolism 2008 7 6 485 495 (Pubitemid 351729204)
53. Odegaard J. I., Ricardo-Gonzalez R. R., Red Eagle A., Vats D., Morel C. R., Goforth M. H., Subramanian V., Mukundan L., Ferrante A. W., Chawla A., Alternative M2 activation of Kupffer cells by PPARdelta ameliorates obesity-induced insulin resistance Cell Metabolism 2008 7 6 496 507 (Pubitemid 351729205)
54. Defaux A., Zurich M. G., Braissant O., Honegger P., Monnet-Tschudi F., Effects of the PPAR- agonist GW501516 in an in vitro model of brain inflammation and antibody-induced demyelination Journal of Neuroinflammation 2009 6, article 15
55. Bondareff W., Mountjoy C. Q., Roth M., Selective loss of neurones of origin of adrenergic projection to cerebral cortex (nucleus locus coeruleus) in senile dementia The Lancet 1981 1 8223 783 784
56. Yankner B. A., New clues to Alzheimer's disease: unraveling the roles of amyloid and tau Nature Medicine 1996 2 8 850 852 (Pubitemid 26296747)
57. Frlich L., Blum-Degen D., Bernstein H. G., Engelsberger S., Humrich J., Laufer S., Muschner D., Thalheimer A., Trk A., Hoyer S., Zchling R., Boissl K. W., Jellinger K., Riederer P., Brain insulin and insulin receptors in aging and sporadic Alzheimer's disease Journal of Neural Transmission 1998 105 4-5 423 438 (Pubitemid 28365027)
58. Bernstein H. G., Ansorge S., Riederer P., Reiser M., Frlich L., Bogerts B., Insulin-degrading enzyme in the Alzheimer's disease brain: prominent localization in neurons and senile plaques Neuroscience Letters 1999 263 2-3 161 164 (Pubitemid 29158953)
59. Markesbery W. R., Carney J. M., Oxidative alterations in Alzheimer's disease Brain Pathology 1999 9 1 133 146 (Pubitemid 29056524)
60. Sayre L. M., Zelasko D. A., Harris P. L. R., Perry G., Salomon R. G., Smith M. A., 4-Hydroxynonenal-derived advanced lipid peroxidation end products are increased in Alzheimer's disease Journal of Neurochemistry 1999 68 5 2092 2097
61. Hald A., Lotharius J., Oxidative stress and inflammation in Parkinson's disease: is there a causal link? Experimental Neurology 2005 193 2 279 290 (Pubitemid 40616179)
62. Dehmer T., Heneka M. T., Sastre M., Dichgans J., Schulz J. B., Protection by pioglitazone in the MPTP model of Parkinson's disease correlates with I kappa B alpha induction and block of NF kappa B and iNOS activation Journal of Neurochemistry 2004 88 2 494 501 (Pubitemid 38084565)
63. Consilvio C., Vincent A. M., Feldman E. L., Neuroinflammation, COX-2, and ALS-A dual role? Experimental Neurology 2004 187 1 1 10 (Pubitemid 38470006)
64. Strokin M., Sergeeva M., Reiser G., Prostaglandin synthesis in rat brain astrocytes is under the control of the n-3 docosahexaenoic acid, released by group VIB calcium-independent phospholipase A2 Journal of Neurochemistry 2007 102 6 1771 1782 (Pubitemid 47329261)
65. Forlenza O. V., Schaeffer E. L., Gattaz W. F., Phospholipase A2 in the central nervous system: implications for neurodegenerative diseases Journal of Neural Transmission 2007 114 2 231 238
66. Ho L., Qin W., Stetka B. S., Pasinetti G. M., Is there a future for cyclo-oxygenase inhibitors in Alzheimer's disease? CNS Drugs 2006 20 2 85 98 (Pubitemid 43261694)
67. Aleshin S., Grabeklis S., Hanck T., Sergeeva M., Reiser G., Peroxisome proliferator-activated receptor (PPAR)- positively controls and PPAR negatively controls cyclooxygenase-2 expression in rat brain astrocytes through a convergence on PPAR / via mutual control of PPAR expression levels Molecular Pharmacology 2009 76 2 414 424
68. Khuntia D., Brown P., Li J., Mehta M. P., Whole-brain radiotherapy in the management of brain metastasis Journal of Clinical Oncology 2006 24 8 1295 1304 (Pubitemid 46622033)
69. Giovagnoli A. R., Boiardi A., Cognitive impairment and quality of life in long-term survivors of malignant brain tumors The Italian Journal of Neurological Sciences 1994 15 9 481 488
70. Monje M. L., Mizumatsu S., Fike J. R., Palmer T. D., Irradiation induces neural precursor-cell dysfunction Nature Medicine 2002 8 9 955 962 (Pubitemid 35033699)
71. Brush J., Lipnick S. L., Phillips T., Sitko J., McDonald J. T., McBride W. H., Molecular mechanisms of late normal tissue injury Seminars in Radiation Oncology 2007 17 2 121 130 (Pubitemid 46467382)
72. Yacoub A., Miller A., Caron R. W., Qiao L., Curiel D. A., Fisher P. B., Hagan M. P., Grant S., Dent P., Radiotherapy-induced signal transduction Endocrine-Related Cancer 2006 13 supplement 1 S99 S114 (Pubitemid 46219252)
73. van Rossum D., Hanisch U. K., Microglia Metabolic Brain Disease 2004 19 3-4 393 411 (Pubitemid 39361196)
74. Gebicke-Haerter P. J., Microglia in neurodegeneration: molecular aspects Microscopy Research and Technique 2001 54 1 47 58 (Pubitemid 32537334)
75. Stollg G., Jander S., The role of microglia and macrophages in the pathophysiology of the CNS Progress in Neurobiology 1999 58 3 233 247 (Pubitemid 29193056)
76. Kyrkanides S., Moore A. H., Olschowka J. A., Daeschner J. C., Williams J. P., Hansen J. T., Kerry O'Banion M., Cyclooxygenase-2 modulates brain inflammation-related gene expression in central nervous system radiation injury Molecular Brain Research 2002 104 2 159 169
77. Ramanan S., Kooshki M., Zhao W., Hsu F. C., Robbins M. E., PPAR ligands inhibit radiation-induced microglial inflammatory responses by negatively regulating NF- B and AP-1 pathways Free Radical Biology and Medicine 2008 45 12 1695 1704
78. Dong X., Dong J., Zhang R., Fan L., Liu L., Wu G., Anti-inflammatory effects of tanshinone IIA on radiation-induced microglia BV-2 cells inflammatory response Cancer Biotherapy and Radiopharmaceuticals 2009 24 6 681 687
79. Lee W. H., Sonntag W. E., Mitschelen M., Yan H., Lee Y. W., Irradiation induces regionally specific alterations in pro-inflammatory environments in rat brain International Journal of Radiation Biology 2010 86 2 132 144
80. Monje M. L., Toda H., Palmer T. D., Inflammatory blockade restores adult hippocampal neurogenesis Science 2003 302 5651 1760 1765 (Pubitemid 37505739)
81. Ramanan S., Kooshki M., Zhao W., Hsu F. C., Riddle D. R., Robbins M. E., The PPARalpha agonist fenofibrate preserves hippocampal neurogenesis and inhibits microglial activation after whole-brain irradiation International Journal of Radiation Oncology Biology Physics 2009 75 3 870 877
82. Kyrkanides S., Olschowka J. A., Williams J. P., Hansen J. T., O'Banion M. K., TNF and IL-1 mediate intercellular adhesion molecule-1 induction via microglia-astrocyte interaction in CNS radiation injury Journal of Neuroimmunology 1999 95 1-2 95 106 (Pubitemid 29173026)
83. Zhao W., Payne V., Tommasi E., Diz D. I., Hsu F. C., Robbins M. E., Administration of the peroxisomal proliferator-activated receptor agonist pioglitazone during fractionated brain irradiation prevents radiation-induced cognitive impairment International Journal of Radiation Oncology Biology Physics 2007 67 1 6 9 (Pubitemid 44959517)
84. Lindberg M., Astrup A., The role of glitazones in management of type 2 diabetes. A dream or a nightmare? Obesity Reviews 2007 8 5 381 384 (Pubitemid 47283947)
85. Crowe M. J., Bresnahan J. C., Shuman S. L., Masters J. N., Beattie M. S., Apoptosis and delayed degeneration after spinal cord injury in rats and monkeys Nature Medicine 1997 3 1 73 76 (Pubitemid 27019144)
86. Jones T. B., McDaniel E. E., Popovich P. G., Inflammatory-mediated injury and repair in the traumatically injured spinal cord Current Pharmaceutical Design 2005 11 10 1223 1236 (Pubitemid 40458268)
87. Profyris C., Cheema S. S., Zang D., Azari M. F., Boyle K., Petratos S., Degenerative and regenerative mechanisms governing spinal cord injury Neurobiology of Disease 2004 15 3 415 436 (Pubitemid 38429958)
88. Esposito E., Paterniti I., Meli R., Bramanti P., Cuzzocrea S., GW0742, A High Affinity Ppar- Gonist, Mediates Protection in an Organotypic Model of Spinal Cord Damage. Spine. In press
89. McTigue D. M., Wei P., Stokes B. T., Proliferation of NG2-positive cells and altered oligodendrocyte numbers in the contused rat spinal cord Journal of Neuroscience 2001 21 10 3392 3400 (Pubitemid 32422804)
90. Almad A., McTigue D. M., Chronic expression of PPAR- by oligodendrocyte lineage cells in the injured rat spinal cord Journal of Comparative Neurology 2010 518 6 785 799